The effects of dexamethasone on rat brain cortical nuclear factor kappa B (NF-κB) in endotoxic shock

Toxicology and Applied Pharmacology

Volumn 214, Issue 3, 2006, Pages 263-269

  Wang, Zhi ^a   Kang, Jin song ^a   Li, Yang ^a   Yuan, Zhao xin ^a   Liu, Shan shan ^a   Sun, Lian kun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Brain injury; Dexamethasone; LPS; NF B

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SYNAPTOTAGMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN TISSUE; CONTROLLED STUDY; CYTOSOL; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE TRANSLOCATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; BLOTTING, WESTERN; CELL NUCLEUS; CEREBRAL CORTEX; DEXAMETHASONE; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROTEIN TRANSPORT; RATS; RATS, WISTAR; SHOCK, SEPTIC;

EID: 33745983855     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.12.014     Document Type: Article

References (35)

1. Aggarwal B.B. Apoptosis and nuclear factor-κB: a tales of association and dissociation. Biochem. Pharmacol. 60 (2000) 1033-1039
2. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A.K., and Struhl (Eds). Current Protocols in Molecular Biology (1989), Greene Publishing/Wiley-Interscience, New York 12.0.1-12.2.10
3. Barnes P.J., and Adcock I.M. NF-κB: a pivotal role on asthma and a new target for therapy. Trends Phamacol. Sci. 18 (1997) 46-50
4. Brandt J.A., Churchill L., Rehman A., Ellis G., Memet S., Israel A., and Krueger J.M. Sleep deprivation increases the activation of nuclear factor kappa B in lateral hypothalamic cells. Brain Res. 1004 (2004) 91-97
5. Carroll J.E., Howard E.F., Hess D.C., Wakade C.G., Chen Q., and Cheng C. Nuclear factor-κB activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res. Mol. Brain Res. 56 (1998) 186-191
6. Celec P. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed. Pharmacother. 58 (2004) 365-371
7. Christman J.W., Lancaster L.H., and Blackwell T.S. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med. 24 (1998) 1131-1138
8. Gaillard P.J., van Der Meide P.H., de Boer A.G., and Breimer D.D. Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis. NeuroReport 12 (2001) 2189-2193
9. Goldring C.E., Reveneau S., Pinard D., and Jeannin J.F. Hyporesponsiveness to lipopolysaccharide alters the composition of NF-κB binding to the regulatory regions of inducible nitric oxide synthase gene. Eur. J. Immunol. 28 (1998) 2960-2970
10. Grilli M., Chiu J.J.-S., and Lenardo M.J. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143 (1993) 1-62
11. Grilli M., Pizzi M., Memo M., and Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 274 (1996) 1383-1385
12. Jones S.B., and Romano F.D. Plasma catecholamines in the conscious rat during endotoxicosis. Circ. Shock 14 (1984) 189-201
13. Kako K., Wakamatsu H., Hamada T., Banasik M., Ohata K., Niki-Kuroiwa T., Suzuki S., Takeuchi J., and Ishida N. Examination of DNA-binding activity of neuronal transcription factors by electrophoretical mobility shift assay. Brain Res. Protoc. 2 (1998) 243-249
14. Kato A., Edwards M.J., and Lentsch A.B. Gene deletion of NF-κB p50 does not alter the hepatic inflammatory response to ischemia/reperfusion. J. Hepatol. 37 (2002) 48-55
15. Kopp E.B., and Ghosh S. NF-κB and rel proteins in innate immunity. Adv. Immunol. 58 (1995) 1-27
16. Korner M., Rattner A., Mauxion F., Sen R., and Citri Y. A brain-specific transcription activator. Neuron 3 (1989) 563-572
17. Lahiri D.K., and Ge Y.W. Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue. Brain Res. Protoc. 5 (2000) 257-265
18. Meffert M.K., and Baltimore D. Physiological functions for brain NF-κB. Trends Neurosci. 28 (2005) 37-43
19. Newton R. Molecular mechanisms of glucocorticoid action: what is important?. Thorax 55 (2000) 603-613
20. Prasad A.V., Pilcher W.H., and Joseph S.A. Nuclear factor-κB in rat brain: enhanced DNA-binding activity following convulsant-induced seizures. Neurosci. Lett. 170 (1994) 145-148
21. Quan N., Whiteside M., Kim L., and Herkenham M. Induction of IκBα mRNA in the central nervous system after peripheral lipopolysaccharide administration: and insitu hybridization histochemistry study in the rat. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10985-10990
22. Rong Y., and Baudry M. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem. 67 (1996) 662-668
23. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
24. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., and Baklwin A.S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15 (1995) 943-953
25. Schmid R.M., and Adler G. NF-κB/Rel/IκB: implications in gastrointestinal diseases. Gastroenterology 118 (2000) 1208
26. Schreck R., Kistler B., and Wirth T. The NF-κB/Rel system of transcription activators. In: Papavassiliou A.G. (Ed). Transcription Factors in Eukaryotes (1997), Landes Bioscience, Austin, TX 153-188
27. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986) 705-716
28. Siebenlist U., Franzoso G., and Brown K. Structure regulation and function of NF-κB. Annu. Rev. Cell Biol. 10 (1994) 405-455
29. Singh A.K., and Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats?. Toxicology 201 (2004) 197-207
30. Udalova I.A., Richardson A., Denys A., Smith C., Ackerman H., Foxwell B., and Kwiatkowski D. Functional consequences of a polymorphism affection NF-κB p50-p50 binding to the TNF promoter region. Mol. Cell. Biol. 20 (2000) 9113-9119
31. Valledor A.F., and Ricote M. Nuclear receptor signaling in macrophages. Biochem. Pharmacol. 67 (2004) 201-212
32. Verma I.M., Stevenson J.k., Schwarz E.M., Van Antwerp D., and Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9 (1995) 2723-2735
33. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30 (2005) 43-52
34. Xaio H., Banks W.A., Niehoff M.L., and Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res. 896 (2001) 36-42
35. Yang K., Mu X.S., and Hayes R.L. Increased cortical nuclear factor-κB (NF-κB) DNA binding activity after traumatic brain injury in rats. Neurosci. Lett. 197 (1995) 101-104